Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

CEFT Panel Peptid

Wirt: Synthetic
Rockland
Produktnummer ABIN6699450
Hersteller Produkt- Nr.: 000-001-l24

Kurzübersicht für CEFT Panel Peptid (ABIN6699450)

Target

CEFT Panel

Quelle

  • 1
Synthetic
  • Protein-Typ

    Synthetic

    Hersteller Produkt- Nr.

    000-001-l24

    Hersteller

    Rockland

    Verwendungszweck

    T-Cell Assay Panel Peptides

    Aufreinigung

    Greater than 90% specific peptide.

    Reinheit

    Greater than 90% specific peptide.
  • Applikationshinweise

    Application Note: T-Cell Assay Panel Control Peptides are suitable for use in ELISA, Western Blot, Dot blot, PCA, and other assays. Control peptide should be used at 1.0 μg per 1.0 μL of antiserum in per assay. Specific conditions for reactivity should be optimized by the end user.

    Other: Control peptide should be used at 1.0 μg per 1.0 μL of antiserum per assay.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Lyophilized

    Rekonstitution

    Reconstitution_Buffer: Restore with deionized water (or equivalent)

    Reconstitution_Volume: 1.0 mL

    Konzentration

    1.0 mg/mL

    Lagerung

    4 °C,-20 °C

    Informationen zur Lagerung

    Store vial at 2 - 8 ° C prior to opening. Aliquot contents and freeze at -20° C or below for extended storage. Avoid cycles of freezing and thawing. Centrifuge product if not completely clear after standing at room temperature. Dilute only prior to immediate use.

    Haltbarkeit

    12 months
  • Target

    CEFT Panel

    Hintergrund

    Synonyms: Influenza A, Influenza M, EBV LMP2A, EBV BMLF1, HCMV pp65, Influenza NP, EBV, EBV EBNA 4NP, EBV RTA, EBV BZLF-1, EBV EBNA 3A, EBV EBNA 3, HCMV, EBV EBNA 3C, EBV EBNA3A, CMV pp65, HCMV, control peptide, blocking peptide

    Background: Pool of 32 HLA class I restricted T cell epitopes from human cytomegalovirus, Epstein-Barr virus and influenza virus. Stimulates the release of IFN-gamma from CD8+ T cells in individuals with certain highly frequent HLA types (HLA: A1, A2, A3, A11, A24, A68, B7, B8, B27, B35, B44). Chosen epitopes are presented by the most common Caucasian HLA types, whose cumulative frequencies represent >100 % of Caucasian individuals. Useful as a peptide specific positive control in ELISPOT, CTL and intracellular cytokine assays using human PBMC.

Sie sind hier:
Chat with us!